{"organizations": [], "uuid": "d3454d42584d805767cc60020fdaba00c633fd72", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180128.html", "section_title": "Archive News &amp; Video for Sunday, 28 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-fuan-pharmaceutical-group-sees-fy/brief-fuan-pharmaceutical-group-sees-fy-2017-net-profit-up-21-6-pct-to-39-7-pct-idUSL4N1PO1MN", "country": "US", "domain_rank": 408, "title": "BRIEF-Fuan Pharmaceutical Group sees FY 2017 net profit up 21.6 pct to 39.7 pct", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.613, "site_type": "news", "published": "2018-01-29T11:16:00.000+02:00", "replies_count": 0, "uuid": "d3454d42584d805767cc60020fdaba00c633fd72"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-fuan-pharmaceutical-group-sees-fy/brief-fuan-pharmaceutical-group-sees-fy-2017-net-profit-up-21-6-pct-to-39-7-pct-idUSL4N1PO1MN", "ord_in_thread": 0, "title": "BRIEF-Fuan Pharmaceutical Group sees FY 2017 net profit up 21.6 pct to 39.7 pct", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-fuan pharmaceutical group", "sentiment": "negative"}, {"name": "reuters) - fuan pharmaceutical group co ltd", "sentiment": "neutral"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29(Reuters) - Fuan Pharmaceutical Group Co Ltd\n* Sees FY 2017 net profit to increase by 21.6 percent to 39.7 percent, or to be 270 million yuan to 310 million yuan\n* Says FY 2016 net profit was 222 million yuan\n* Says increased operating revenue and gross margin and inclusion of new company are the main reasons for the forecast\nSource text in Chinese: goo.gl/d9hYwX\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/d9hYwX", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-29T11:16:00.000+02:00", "crawled": "2018-01-29T21:55:34.000+02:00", "highlightTitle": ""}